DR. JEFFREY BURNETT KOPP, MD
Osteopathic Medicine in Bethesda, MD
License number
Maryland D0038010
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
10 Nih Bdg 10, Bethesda, MD 20892
Phone
(301) 594-3403
(301) 402-0014 (Fax)
(301) 402-0014 (Fax)
Personal information
See more information about JEFFREY BURNETT KOPP at radaris.comName
Address
Phone
614 Hopkins Landing Dr, Essex, MD 21221
5510 Lincoln St, Bethesda, MD 20817
3220 Mount Carmel Rd, Upperco, MD 21155
3458 Marble Arch Dr, Pasadena, MD 21122
4399 Redtail Dr, Hampstead, MD 21074
Professional information
See more information about JEFFREY BURNETT KOPP at trustoria.com
Jeffrey Burnett Kopp, Bethesda MD
Jeffrey Burnett Kopp, Bethesda MD
Specialties:
Nephrologist
Address:
10 Center Dr, Bethesda, MD 20892
Education:
University of Pennsylvania, Perelman School of Medicine - Doctor of Medicine
University of Washington Medical Center - Fellowship - Nephrology (Internal Medicine)
University of Washington Medical Center - Residency - Internal Medicine
University of Washington Medical Center - Fellowship - Nephrology (Internal Medicine)
University of Washington Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Nephrology (Internal Medicine)
Jeffrey Burnett Kopp, Bethesda MD
Jeffrey Burnett Kopp, Bethesda MD
Specialties:
Internal Medicine, Nephrology, Neurology
Work:
National Institutes of Health
10 Ctr Dr, Bethesda, MD 20892
10 Ctr Dr, Bethesda, MD 20892
Education:
University of Pennsylvania(1980)
Dr. Jeffrey B Kopp - MD (Doctor of Medicine)
Dr. Jeffrey B Kopp - MD (Doctor of Medicine)
Hospitals:
10 Ctr Dr #NIH, Bethesda 20892
10 Ctr Dr #NIH, Bethesda 20892
10 Ctr Dr #NIH, Bethesda 20892
Education:
Medical Schools
Perelman School of Medicine University of Pennsylvania
Graduated: 1980
Perelman School of Medicine University of Pennsylvania
Graduated: 1980
Single Nucleotide Polymorphisms Associated With Renal Disease
Single Nucleotide Polymorphisms Associated With Renal Disease
US Patent:
2010029, Nov 25, 2010
Filed:
Jan 30, 2009
Appl. No.:
12/864218
Inventors:
Cheryl Winkler - Gaithersburg MD, US
George Nelson - Thurmont MD, US
Jeffrey B. Kopp - Bethesda MD, US
Michael W. Smith - Jefferson MD, US
Randall Johnson - Frederick MD, US
George Nelson - Thurmont MD, US
Jeffrey B. Kopp - Bethesda MD, US
Michael W. Smith - Jefferson MD, US
Randall Johnson - Frederick MD, US
International Classification:
C12Q 1/68, C40B 40/06
US Classification:
435 6, 506 16
Abstract:
Methods for determining the genetic predisposition of a human subject to developing renal disease, such as focal segmental glomerulosclerosis (FSGS) or end-stage kidney disease are provided herein. These methods include methods for detecting renal disease, or determining the risk of developing renal disease in a human subject, such as a subject of African ancestry. The methods utilize the detection of one or more haplotype blocks comprising at least two tag single nucleotide polymorphisms (SNPs) in a non-coding region of a MYH9 gene or detecting the presence of at least one tag SNP in a non-coding region of a MYH9 gene. An array for detecting a genetic predisposition to renal disease using probes complementary to the tag SNPs in the non-coding region of the MYH9 gene are also disclosed.
Monoclonal Antibodies To Hiv-1 And Methods Of Using Same
Monoclonal Antibodies To Hiv-1 And Methods Of Using Same
US Patent:
2008029, Nov 27, 2008
Filed:
Jun 22, 2005
Appl. No.:
11/630880
Inventors:
Jeffrey B. Kopp - Bethesda MD, US
Terence M. Phillips - Washington DC, US
Ulrich Schubert - Jena/Thuringen, DE
John Yewell - Silver Spring MD, US
Terence M. Phillips - Washington DC, US
Ulrich Schubert - Jena/Thuringen, DE
John Yewell - Silver Spring MD, US
International Classification:
C12Q 1/70, C07K 16/18, C12N 5/06
US Classification:
435 5, 5303871, 53038835, 5303873, 5303913, 435346
Abstract:
The present invention provides monoclonal antibodies to HIV-1 Vpr and hybridoma cell lines that produce the monoclonal antibodies to HIV-1 Vpr. Methods for use of such antibodies in the detection of HIV-1 infection are also provided.